Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,091.45
+15.760.76%
Number of Gainers:682
Number of Losers:315
Number of Flat:27
PE:- -
High:2,096.63
Open:2,075.69
Low:2,075.69
Close:2,075.69
Volume:6.21B
Turnover:696.72B
Market Cap:97.36T
Float Cap:91.13T

Loading ...

Toronto-Dominion Bank Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

AGG ETF Gains 0.2%

Dow Jones
·
Sep 26

BNDX ETF Climbs 0.1%

Dow Jones
·
Sep 26

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

Manulife Financial Corp. Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Super Micro Computer Inc. Stock Rallies 4.2%, Outperforms Peers

Dow Jones
·
Sep 26

Nutrien Ltd. Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Texas Instruments Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

PayPal Holdings Inc. Stock Rises 4.6%, Outperforms Peers

Dow Jones
·
Sep 26

CrowdStrike Holdings Inc. Cl a Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Pool Corporation Announces Director Appointment

THOMSON REUTERS
·
Sep 26

Enbridge Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

OpenAI Works to Understand Full Scope of Agent Activity as User Data Leak Emerges

Reuters
·
Sep 26

Moderately bullish activity in American Airlines with shares up 3.9%

TIPRANKS
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26

Merck & Co - Patient Enrollment Continues in Ideate-Lung02 Phase 3 Trial for Ifinatamab Deruxtecan

THOMSON REUTERS
·
Sep 26

Merck & Co - Two Additional Phase 3 Trials Underway for Ifinatamab Deruxtecan in Crpc and Escc

THOMSON REUTERS
·
Sep 26

Top News Today/Canada: Wholesale Trade Weakened in August

Dow Jones
·
Sep 26

BioAge Labs to Present at Upcoming Investor Conferences

GlobeNewswire
·
Sep 26